PATH vs SENS · P/E 19, rev $1.61B vs rev $22.5M
Uipath Inc (PATH) versus Senseonics Holdings, Inc. Common Stock (SENS) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Senseonics Holdings, Inc. Common Stock (SENS) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SENS revenue for 2024-12-31 was $22.5M. Net income was -$78.6M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. SENS currently screens at market cap $377.4M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SENS currently screens at market cap $377.4M.
Not investment advice. Open the PATH and SENS stock pages for the full models.
Not investment advice.